Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{$index + 1}}. {{ watchedTerm.term }} ({{watchedTerm.accId}})
{{gene.symbol}}: {{ gene.description }}
Save what matters to you
{{ loginError }}
Sign in with your RGD account
x
Send Message
Gene: Gmfg (glia maturation factor, gamma) Rattus norvegicus
Analyze
Symbol:
Gmfg
Name:
glia maturation factor, gamma
RGD ID:
620506
Description:
Predicted to have Arp2/3 complex binding activity. Predicted to be involved in actin filament debranching and negative regulation of Arp2/3 complex-mediated actin nucleation. Orthologous to human GMFG (glia maturation factor gamma); INTERACTS WITH 1-naphthyl isothiocyanate; 17beta-estradiol; 17beta-estradiol 3-benzoate.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Also known as:
glia maturation factor gamma; GMF-gamma
RGD Orthologs
Alliance Genes
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
GMFG (glia maturation factor gamma)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Mus musculus (house mouse):
Gmfg (glia maturation factor, gamma)
HGNC
Treefam, EggNOG, OrthoMCL, NCBI, OMA, HomoloGene, Inparanoid, Panther, OrthoDB, Ensembl
Chinchilla lanigera (long-tailed chinchilla):
Gmfg (glia maturation factor gamma)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
GMFG (glia maturation factor gamma)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
GMFG (glia maturation factor gamma)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Gmfg (glia maturation factor gamma)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
GMFG (glia maturation factor gamma)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (African green monkey):
GMFG (glia maturation factor gamma)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Gmfg (glia maturation factor gamma)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
GMFB (glia maturation factor beta)
HGNC
OrthoDB
Alliance orthologs 3
Homo sapiens (human):
GMFG (glia maturation factor gamma)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|TreeFam)
Mus musculus (house mouse):
Gmfg (glia maturation factor, gamma)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|TreeFam)
Saccharomyces cerevisiae (baker's yeast):
AIM7
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OrthoFinder|PANTHER|PhylomeDB|TreeFam)
Drosophila melanogaster (fruit fly):
GMF
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|TreeFam)
Caenorhabditis elegans (roundworm):
Y50D7A.10
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB)
Latest Assembly:
Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl mRatBN7.2 1 83,728,797 - 83,739,189 (+) NCBI Rnor_6.0 Ensembl 1 85,312,528 - 85,317,968 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_6.0 1 85,312,473 - 85,322,860 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_5.0 1 86,528,117 - 86,539,458 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 1 83,551,609 - 83,557,015 (+) NCBI RGSC3.4 rn4 RGSC3.4 RGSC_v3.1 1 83,630,142 - 83,635,126 (+) NCBI Celera 1 78,129,937 - 78,135,343 (+) NCBI Celera Cytogenetic Map 1 q21 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Imported Disease Annotations - CTD
1,2-dichloroethane decreases expression ISO RGD:736891 6480464 ethylene dichloride results in decreased expression of GMFG mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:736891 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of GMFG mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:736891 6480464 1, 2-Dimethylhydrazine results in increased expression of GMFG mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of GMFG mRNA CTD PMID:25380136 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GMFG mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GMFG mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736891 6480464 Tetrachlorodibenzodioxin results in decreased expression of GMFG mRNA CTD PMID:19770486 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of GMFG mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO RGD:736891 6480464 bis4-hydroxyphenylsulfone results in increased expression of GMFG mRNA CTD PMID:30951980 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of GMFG mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of GMFG mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO RGD:736890 6480464 Antirheumatic Agents results in decreased expression of GMFG mRNA CTD PMID:24449571 benzo[a]pyrene multiple interactions ISO RGD:736891 6480464 AHR protein affects the reaction [Benzoapyrene affects the expression of GMFG mRNA], Benzoapyrene promotes the reaction [AHR protein binds to GMFG promoter] CTD PMID:19654925 , PMID:22228805 benzo[a]pyrene affects methylation ISO RGD:736890 6480464 Benzoapyrene affects the methylation of GMFG promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:736890 6480464 Benzoapyrene results in decreased methylation of GMFG 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:736891 6480464 Benzoapyrene results in increased expression of GMFG mRNA CTD PMID:19770486 bisphenol F increases expression ISO RGD:736891 6480464 bisphenol F results in increased expression of GMFG mRNA CTD PMID:30951980 butanal increases expression ISO RGD:736890 6480464 butyraldehyde results in increased expression of GMFG mRNA CTD PMID:26079696 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of GMFG mRNA CTD PMID:22110744 carbon nanotube decreases expression ISO RGD:736891 6480464 Nanotubes, Carbon results in decreased expression of GMFG mRNA CTD PMID:25554681 cisplatin increases expression ISO RGD:736890 6480464 Cisplatin results in increased expression of GMFG mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:736890 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of GMFG mRNA CTD PMID:27392435 copper atom decreases expression EXP 6480464 Copper results in decreased expression of GMFG mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of GMFG mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:736890 6480464 Copper Sulfate results in increased expression of GMFG mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:736891 6480464 Asbestos, Crocidolite results in decreased expression of GMFG mRNA CTD PMID:29279043 cyclosporin A decreases expression ISO RGD:736891 6480464 Cyclosporine results in decreased expression of GMFG mRNA CTD PMID:19770486 disodium selenite increases expression ISO RGD:736890 6480464 Sodium Selenite results in increased expression of GMFG mRNA CTD PMID:18175754 dorsomorphin multiple interactions ISO RGD:736890 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of GMFG mRNA CTD PMID:27188386 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of GMFG mRNA CTD PMID:29391264 folic acid decreases expression ISO RGD:736891 6480464 Folic Acid results in decreased expression of GMFG mRNA CTD PMID:25629700 folic acid multiple interactions ISO RGD:736891 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of GMFG mRNA] CTD PMID:22206623 fonofos decreases methylation ISO RGD:736890 6480464 Fonofos results in decreased methylation of GMFG promoter CTD PMID:22847954 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of GMFG mRNA CTD PMID:22061828 glafenine increases expression EXP 6480464 Glafenine results in increased expression of GMFG mRNA CTD PMID:24136188 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of GMFG mRNA CTD PMID:25380136 nickel atom increases expression ISO RGD:736890 6480464 Nickel results in increased expression of GMFG mRNA CTD PMID:25583101 paracetamol increases expression ISO RGD:736890 6480464 Acetaminophen results in increased expression of GMFG mRNA CTD PMID:22230336 parathion decreases methylation ISO RGD:736890 6480464 Parathion results in decreased methylation of GMFG promoter CTD PMID:22847954 perfluorododecanoic acid increases expression EXP 6480464 perfluorododecanoic acid results in increased expression of GMFG protein CTD PMID:19854247 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of GMFG mRNA CTD PMID:18158353 pirinixic acid increases expression ISO RGD:736891 6480464 pirinixic acid results in increased expression of GMFG mRNA CTD PMID:18301758 quercetin increases expression ISO RGD:736890 6480464 Quercetin results in increased expression of GMFG mRNA CTD PMID:21632981 SB 431542 multiple interactions ISO RGD:736890 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of GMFG mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:736890 6480464 Silicon Dioxide analog results in increased expression of GMFG mRNA CTD PMID:25895662 Soman increases expression EXP 6480464 Soman results in increased expression of GMFG mRNA CTD PMID:19281266 terbufos decreases methylation ISO RGD:736890 6480464 terbufos results in decreased methylation of GMFG promoter CTD PMID:22847954 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of GMFG mRNA CTD PMID:32741896 tolcapone decreases expression EXP 6480464 tolcapone results in decreased expression of GMFG mRNA CTD PMID:24136188 valproic acid increases expression ISO RGD:736890 6480464 Valproic Acid results in increased expression of GMFG mRNA CTD PMID:24383497 , PMID:28001369 valproic acid multiple interactions ISO RGD:736890 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of GMFG mRNA CTD PMID:27188386 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of GMFG mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of GMFG mRNA CTD PMID:23034163
References
Additional References at PubMed
Genomics
QTLs in Region (Rnor_6.0)
1554320 Bmd1 Bone mineral density QTL 1 12.2 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 1 254393 86904217 Rat 631688 Hcas2 Hepatocarcinoma susceptibility QTL 2 3 0.0001 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 1 5655769 122614963 Rat 4889451 Eae29 Experimental allergic encephalomyelitis QTL 29 5.51 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis severity score (CMO:0001419) 1 5655772 85706974 Rat 631495 Bp96 Blood pressure QTL 96 4.52 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 23406428 108057505 Rat 1358359 Sradr1 Stress Responsive Adrenal Weight QTL 1 4.74 adrenal gland mass (VT:0010420) both adrenal glands wet weight (CMO:0000164) 1 25951907 130917265 Rat 70225 Bp58 Blood pressure QTL 58 3.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 34993530 173445086 Rat 1300172 Bp172 Blood pressure QTL 172 3.56 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 1 35377508 94364229 Rat 10059597 Bp377 Blood pressure QTL 377 3.42 0.025 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 35377692 217372257 Rat 2302059 Pia36 Pristane induced arthritis QTL 36 3.8 0.001 blood immunoglobulin amount (VT:0002460) serum immunoglobulin G1 level (CMO:0002115) 1 41907249 86907249 Rat 2313051 Bss57 Bone structure and strength QTL 57 3.7 0.0001 tibia strength trait (VT:1000284) bone polar moment of inertia (CMO:0001558) 1 43579208 126240667 Rat 2313059 Bss55 Bone structure and strength QTL 55 3.2 0.0001 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 1 43579208 126240667 Rat 2313072 Bss53 Bone structure and strength QTL 53 4.3 0.0001 tibia length (VT:0004357) tibia length (CMO:0000450) 1 43579208 126240667 Rat 2313078 Bss54 Bone structure and strength QTL 54 3.5 0.0001 tibia area (VT:1000281) tibia midshaft cross-sectional area (CMO:0001717) 1 43579208 126240667 Rat 2313094 Bss58 Bone structure and strength QTL 58 3.7 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 1 43579208 126240667 Rat 2313098 Bmd70 Bone mineral density QTL 70 3.6 0.0001 tibia mineral mass (VT:1000283) cortical volumetric bone mineral density (CMO:0001730) 1 43579208 126240667 Rat 2313099 Bss56 Bone structure and strength QTL 56 2.4 0.0001 tibia size trait (VT:0100001) tibia midshaft endosteal cross-sectional area (CMO:0001716) 1 43579208 126240667 Rat 2313402 Anxrr24 Anxiety related response QTL 24 aggression-related behavior trait (VT:0015014) tameness/aggressiveness composite score (CMO:0002136) 1 49147799 156446783 Rat 1578649 Bmd8 Bone mineral density QTL 8 4.9 femur mineral mass (VT:0010011) trabecular volumetric bone mineral density (CMO:0001729) 1 49578577 94578577 Rat 1578654 Bss10 Bone structure and strength QTL 10 4 femur morphology trait (VT:0000559) femoral neck cortical cross-sectional area (CMO:0001702) 1 49578577 169852184 Rat 634314 Niddm44 Non-insulin dependent diabetes mellitus QTL 44 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 1 49578693 217054291 Rat 6903308 Scl36 Serum cholesterol QTL 36 2 0.0125 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 1 50522714 94225616 Rat 61342 Bp27 Blood pressure QTL 27 3.4 0.0006 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 57761301 104391981 Rat 2300164 Bmd44 Bone mineral density QTL 44 5.4 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 1 58209327 103209327 Rat 2298545 Neuinf8 Neuroinflammation QTL 8 4.6 nervous system integrity trait (VT:0010566) spinal cord beta-2 microglobulin mRNA level (CMO:0002125) 1 58354072 161711996 Rat 7421628 Bp361 Blood pressure QTL 361 0.001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 1 64588516 125875986 Rat 1300121 Hrtrt1 Heart rate QTL 1 3.7 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 1 66113339 122614963 Rat 631512 Scl6 Serum cholesterol level QTL 6 9.6 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 1 67227683 94201552 Rat 1549903 Bp267 Blood pressure QTL 267 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 1 79134941 113593716 Rat 7411712 Strs4 Sensitivity to stroke QTL 4 8.7 cerebrum integrity trait (VT:0010549) percentage of study population developing cerebrovascular lesions during a period of time (CMO:0000932) 1 79689548 124689548 Rat 61433 Cia2 Collagen induced arthritis QTL 2 5 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 1 79689765 94909507 Rat 1578780 Cm52 Cardiac mass QTL 52 3.3 0.0001 heart mass (VT:0007028) heart wet weight (CMO:0000069) 1 82788437 239853971 Rat 10054135 Gmadr2 Adrenal mass QTL 2 1.97 0.0129 adrenal gland mass (VT:0010420) both adrenal glands wet weight (CMO:0000164) 1 83502376 128502376 Rat 2313083 Bmd74 Bone mineral density QTL 74 4 0.0001 tibia mineral mass (VT:1000283) total volumetric bone mineral density (CMO:0001728) 1 83656882 126240667 Rat